InvestSMART

Acrux Limited (ASX: ACR) - Announcements

- Current share price for ACR : $0.010

ASX company news and announcements for Acrux Limited (ACR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acrux Limited (ACR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acrux Limited (ACR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acrux Limited (ACR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Code of Conduct 24 Jun 2021 1:27PM $0.138 $0.010 fallen by 92.73%
$6 Acrux Receives FDA Approval - Generic Efinaconazole Solution 22 Jun 2021 9:40AM $0.115 $0.010 fallen by 91.30%
$6 Notification of cessation of securities - ACR 21 Jun 2021 3:52PM $0.115 $0.010 fallen by 91.30%
$6 Change in Company Secretary 21 Jun 2021 8:55AM $0.115 $0.010 fallen by 91.30%
$6 Change of Director's Interest Notice - Ross Dobinson 17 Jun 2021 12:34PM $0.115 $0.010 fallen by 91.30%
$6 Application for quotation of securities - ACR 17 Jun 2021 12:31PM $0.115 $0.010 fallen by 91.30%
$6 Acrux confirms patent challenge 8 Jun 2021 8:32AM $0.140 $0.010 fallen by 92.86%
$6 Final Director's Interest Notice - amended 4 Jun 2021 1:56PM $0.140 $0.010 fallen by 92.86%
$6 Final Director's Interest Notice - Mr Norman Gray 4 Jun 2021 1:36PM $0.140 $0.010 fallen by 92.86%
$6 Initial Director's Interest Notice - Mr Don Brumley 4 Jun 2021 1:33PM $0.140 $0.010 fallen by 92.86%
$6 Acrux Limited Announces Board Appointment 4 Jun 2021 1:33PM $0.140 $0.010 fallen by 92.86%
$6 R&D Tax Incentive Rebate - Overseas Finding Application 31 May 2021 12:51PM $0.140 $0.010 fallen by 92.86%
$6 Appendix 2A 18 May 2021 8:16AM $0.140 $0.010 fallen by 92.86%
$6 R&D Tax Incentive Rebate - Overseas Finding Application 30 Apr 2021 12:25PM $0.140 $0.010 fallen by 92.86%
$6 Appendix 2A 15 Apr 2021 4:32PM $0.150 $0.010 fallen by 93.33%
$6 Acrux's fourth generic dossier accepted by FDA for review 15 Apr 2021 10:06AM $0.150 $0.010 fallen by 93.33%
$6 Change of Director's Interest Notice - Ross Dobinson 15 Mar 2021 1:36PM $0.155 $0.010 fallen by 93.55%
$6 Appendix 2A 15 Mar 2021 1:34PM $0.155 $0.010 fallen by 93.55%
$6 Acrux Investor Presentation 25 Feb 2021 10:20AM $0.180 $0.010 fallen by 94.44%
$6 Appendix 4D and Half Year Accounts - for the 31 Dec ac 25 Feb 2021 10:19AM $0.180 $0.010 fallen by 94.44%
$6 Appendix 2A 15 Feb 2021 5:33PM $0.180 $0.010 fallen by 94.44%
$6 Amended Appendix 3Y - Geoff Brooke 5 Feb 2021 4:33PM $0.180 $0.010 fallen by 94.44%
$6 Appendix 2A 4 Feb 2021 2:31PM $0.175 $0.010 fallen by 94.29%
$6 Appendix 3G 4 Feb 2021 2:28PM $0.175 $0.010 fallen by 94.29%
$6 Change of Director's Interest Notice 4 Feb 2021 1:47PM $0.175 $0.010 fallen by 94.29%

301 - 325 of 709 results

Page 13 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.